Robert Whitfield MDAmerica's Breast Implant Illness Expert™

BIA-ALCL Usually Arises in the Capsule or Fluid

1 Oct 2026 · 1 min

Watch on YouTube

0:54

In this segment, Dr. Robert Whitfield explains that breast implant‑associated anaplastic large cell lymphoma (BIA‑ALCL) originates in the fluid surrounding the implant and the fibrous capsule that the body forms around it, rather than in the breast tissue itself. He references multiple authoritative sources—including the Open Evidence AI literature platform, NCCN guidelines, pathology references, and the FDA—to support the classification of BIA‑ALCL as a disease of the implant capsule. Dr. Whitfield emphasizes that this distinction is crucial because the term "breast implant" can lead patients to mistakenly think the condition is a form of breast cancer, whereas it is actually a lymphoma linked to the capsule and surrounding fluid.

Chapters

Where does it arise? We find those cells in the fluid around the implant and in the fibrous capsule, and that's the scar layer that your body forms around the implant. So per Open Evidence, which is an AI platform that we can utilize as physicians to access literature, both that and drawing on the NCCN guidelines and pathology sources, it describes it as a disease of the implant capsule. Rather than the breast itself, as I mentioned previously. The FDA also says the same thing. In most cases, it's found in the scar tissue and the fluid near the implant, not in the breast tissue itself. That distinction matters. People hear breast implant and cancer in the same sentence and assume that it is a breast cancer, which it is not. It is a lymphoma associated with the capsule and the fluid around some implants.